Actinobacillus equuli
Species of bacterium
Actinobacillus equuli is a species of bacterium in the family Pasteurellaceae. It is known to be a pathogen in horses, causing a condition known as sleepy foal disease.
Morphology[edit]
Actinobacillus equuli is a Gram-negative bacterium. It is a non-motile, facultatively anaerobic organism. The cells are typically rod-shaped and can form chains.
Pathogenicity[edit]
Actinobacillus equuli is primarily known for causing disease in equine species. It is associated with septicemia in newborn foals, a condition often referred to as "sleepy foal disease." The bacterium can also cause peritonitis, nephritis, and arthritis in horses.
Sleepy Foal Disease[edit]
Sleepy foal disease is a serious condition affecting newborn foals. It is characterized by lethargy, fever, and septicemia. The disease is often fatal if not treated promptly. The bacterium is typically transmitted from the mare to the foal during or shortly after birth.
Diagnosis[edit]
Diagnosis of Actinobacillus equuli infection is typically made through bacterial culture and identification. The bacterium can be isolated from blood, tissue, or other body fluids. On sheep blood agar, A. equuli can exhibit both beta and gamma hemolysis, as shown in the image.
Treatment[edit]
Treatment of infections caused by Actinobacillus equuli involves the use of appropriate antibiotics. Early intervention is crucial for the successful treatment of sleepy foal disease. Supportive care, including fluid therapy, may also be necessary.
Prevention[edit]
Preventive measures include good hygiene practices during foaling and ensuring that foals receive adequate colostrum to boost their immune system. Monitoring mares for signs of infection can also help prevent transmission to foals.
Related pages[edit]
Actinobacillus equuli[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian